SNCA and Parkinson disease: Microglia from PD patients with LRRK2-G2019S mutation also increase phagocytosis through cytoskeleton remodelling factors [137] PD-related mutations in LRRK2 may affect the balance between microglia and α-synuclein, leading to cell dysfunction and neurodegeneration [134].